Cargando…

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

BACKGROUND: Adjuvant endocrine therapy is recommended for women with oestrogen receptor-positive breast cancer, but many women do not take the medication as directed and they stop treatment before completing the standard 5-year duration. METHODS: This retrospective cohort study conducted between 199...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makubate, B, Donnan, P T, Dewar, J A, Thompson, A M, McCowan, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629427/ https://www.ncbi.nlm.nih.gov/pubmed/23519057 http://dx.doi.org/10.1038/bjc.2013.116

Ejemplares similares

Completion of 5-year adjuvant endocrine therapy in the community
por: Makubate, B, et al.
Publicado: (2010)

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
por: McCowan, C, et al.
Publicado: (2008)

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
por: McCowan, C, et al.
Publicado: (2013)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
por: Fraser, D M, et al.
Publicado: (2014)

Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study
por: Valachis, Antonis, et al.
Publicado: (2016)

A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer
por: Harrow, Alison, et al.
Publicado: (2014)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study
por: Schiza, Aglaia, et al.
Publicado: (2020)

Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
por: Fadelu, Temidayo A., et al.
Publicado: (2022)

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
por: Park, Ko Un, et al.
Publicado: (2021)

The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy
por: Waaijer, M. E.C., et al.
Publicado: (2023)

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
por: Persson, Mia, et al.
Publicado: (2016)

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
por: Lee, Joo Yun, et al.
Publicado: (2018)

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
por: Harborg, Sixten, et al.
Publicado: (2020)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience
por: Levy, Julia, et al.
Publicado: (2022)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
por: Eraso, Yolanda
Publicado: (2019)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
por: Arpino, Grazia, et al.
Publicado: (2015)

Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark
por: Collin, Lindsay J, et al.
Publicado: (2018)

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence
por: Brett, Jo, et al.
Publicado: (2018)

The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry
por: Cloud, Ann J., et al.
Publicado: (2015)

The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
por: van Dooijeweert, C., et al.
Publicado: (2021)

Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study
por: Plym, Anna, et al.
Publicado: (2020)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

Vitamin C intake and breast cancer mortality in a cohort of Swedish women
por: Harris, H R, et al.
Publicado: (2013)

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?
por: Keim-Malpass, Jessica, et al.
Publicado: (2018)

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore
por: Ali, Eskinder Eshetu, et al.
Publicado: (2017)

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
por: Ragusi, M. A. A., et al.
Publicado: (2022)

Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study
por: Krotneva, Stanimira, et al.
Publicado: (2013)

Association between facility-level adherence to phosphorus management guidelines and mortality in haemodialysis patients: a prospective cohort study
por: Itaya, Takahiro, et al.
Publicado: (2021)

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography
por: Jacklyn, Gemma, et al.
Publicado: (2016)

Coffee and black tea consumption and breast cancer mortality in a cohort of Swedish women
por: Harris, H R, et al.
Publicado: (2012)

Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk
por: Sund, Maria, et al.
Publicado: (2023)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland
por: Simpson, Colin R, et al.
Publicado: (2022)

Wait times for breast cancer care
por: Saint-Jacques, N, et al.
Publicado: (2007)

Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom
por: McGuinness, Serena, et al.
Publicado: (2022)

Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study
por: Johns, Louise E, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mh1kd0h17p9hcr7bt9rlv53o49